Skip to main content
. Author manuscript; available in PMC: 2009 Mar 1.
Published in final edited form as: Neurobiol Aging. 2006 Nov 27;29(3):379–396. doi: 10.1016/j.neurobiolaging.2006.10.012

Figure 1.

Figure 1

Comparison of concentrations of tyrosine hydroxylase (TH) and dopamine transporter (DAT) the caudate nucleus (CN), putamen (Pu) and ventral striatum (ventralmost part of the putamen and nucleus accumbens; VSTR) of control subjects and patients with Parkinson's disease without (PD) or with dementia (PDD). Bar graphs represent the mean±S.E. of the amount (arbitrary units) of TH (A) and DAT (B) in the striatal measured by quantitative Western blotting as described in Materials and Methods. The data were statistically analyzed separately for individual brain regions by one-way ANOVA with Group (control, PD, PDD) as main factor followed by Bonferroni/Dunn post hoc test. * - p<0.05, ** - p<0.01, * - p<0.001 to control.